Double-Blind, Placebo-Controlled, Randomized Study Comparing 0.0003% Calcitriol with 0.1% Tacrolimus Ointments for the Treatment of Endemic Pityriasis Alba

Background. Pityriasis alba (PA) is a frequent cause of consultation in tropical areas due to its chronic course, frequent relapses, and notorious hypopigmented lesions in pediatric dark skin populations. Currently, no treatment is widely accepted. Objective. To assess the efficacy of 0.0003% calcit...

Full description

Saved in:
Bibliographic Details
Main Authors: Berenice Moreno-Cruz, Bertha Torres-Álvarez, Diana Hernández-Blanco, Juan Pablo Castanedo-Cazares
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Dermatology Research and Practice
Online Access:http://dx.doi.org/10.1155/2012/303275
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832545444171874304
author Berenice Moreno-Cruz
Bertha Torres-Álvarez
Diana Hernández-Blanco
Juan Pablo Castanedo-Cazares
author_facet Berenice Moreno-Cruz
Bertha Torres-Álvarez
Diana Hernández-Blanco
Juan Pablo Castanedo-Cazares
author_sort Berenice Moreno-Cruz
collection DOAJ
description Background. Pityriasis alba (PA) is a frequent cause of consultation in tropical areas due to its chronic course, frequent relapses, and notorious hypopigmented lesions in pediatric dark skin populations. Currently, no treatment is widely accepted. Objective. To assess the efficacy of 0.0003% calcitriol and 0.1% tacrolimus ointments compared with placebo in the treatment of endemic PA. Methods. Twenty-eight children aged 3–17 years with 56 symmetrical lesions and phototype IV-V, were randomly assigned to receive the treatments on target lesions on the face. Improvement was evaluated at baseline and 8 weeks later clinically and by digital quantification of the affected area, colorimetry, and transepidermal water loss (TEWL). Results. Tacrolimus and calcitriol ointments induced a mean improvement of 68%, compared to 44% of placebo. We found an elevated TEWL in PA lesions. In the treated plaques, the reduction of the affected area was associated with improvement of pigmentation and TEWL. Conclusions. Calcitriol and tacrolimus induced similar repigmentation in endemic PA lesions. Melanogenic, anti-inflammatory, and barrier defect restoration properties of these drugs may explain these findings.
format Article
id doaj-art-7233166823984028bd0d4f70a69ae2ab
institution Kabale University
issn 1687-6105
1687-6113
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Dermatology Research and Practice
spelling doaj-art-7233166823984028bd0d4f70a69ae2ab2025-02-03T07:25:53ZengWileyDermatology Research and Practice1687-61051687-61132012-01-01201210.1155/2012/303275303275Double-Blind, Placebo-Controlled, Randomized Study Comparing 0.0003% Calcitriol with 0.1% Tacrolimus Ointments for the Treatment of Endemic Pityriasis AlbaBerenice Moreno-Cruz0Bertha Torres-Álvarez1Diana Hernández-Blanco2Juan Pablo Castanedo-Cazares3Dermatology Department, Hospital Central “Dr. Ignacio Morones Prieto”, Universidad Autónoma de San Luis Potosí, Avenida Carranza No. 2395, CP 78210, San Luis Potosi, MexicoDermatology Department, Hospital Central “Dr. Ignacio Morones Prieto”, Universidad Autónoma de San Luis Potosí, Avenida Carranza No. 2395, CP 78210, San Luis Potosi, MexicoDermatology Department, Hospital Central “Dr. Ignacio Morones Prieto”, Universidad Autónoma de San Luis Potosí, Avenida Carranza No. 2395, CP 78210, San Luis Potosi, MexicoDermatology Department, Hospital Central “Dr. Ignacio Morones Prieto”, Universidad Autónoma de San Luis Potosí, Avenida Carranza No. 2395, CP 78210, San Luis Potosi, MexicoBackground. Pityriasis alba (PA) is a frequent cause of consultation in tropical areas due to its chronic course, frequent relapses, and notorious hypopigmented lesions in pediatric dark skin populations. Currently, no treatment is widely accepted. Objective. To assess the efficacy of 0.0003% calcitriol and 0.1% tacrolimus ointments compared with placebo in the treatment of endemic PA. Methods. Twenty-eight children aged 3–17 years with 56 symmetrical lesions and phototype IV-V, were randomly assigned to receive the treatments on target lesions on the face. Improvement was evaluated at baseline and 8 weeks later clinically and by digital quantification of the affected area, colorimetry, and transepidermal water loss (TEWL). Results. Tacrolimus and calcitriol ointments induced a mean improvement of 68%, compared to 44% of placebo. We found an elevated TEWL in PA lesions. In the treated plaques, the reduction of the affected area was associated with improvement of pigmentation and TEWL. Conclusions. Calcitriol and tacrolimus induced similar repigmentation in endemic PA lesions. Melanogenic, anti-inflammatory, and barrier defect restoration properties of these drugs may explain these findings.http://dx.doi.org/10.1155/2012/303275
spellingShingle Berenice Moreno-Cruz
Bertha Torres-Álvarez
Diana Hernández-Blanco
Juan Pablo Castanedo-Cazares
Double-Blind, Placebo-Controlled, Randomized Study Comparing 0.0003% Calcitriol with 0.1% Tacrolimus Ointments for the Treatment of Endemic Pityriasis Alba
Dermatology Research and Practice
title Double-Blind, Placebo-Controlled, Randomized Study Comparing 0.0003% Calcitriol with 0.1% Tacrolimus Ointments for the Treatment of Endemic Pityriasis Alba
title_full Double-Blind, Placebo-Controlled, Randomized Study Comparing 0.0003% Calcitriol with 0.1% Tacrolimus Ointments for the Treatment of Endemic Pityriasis Alba
title_fullStr Double-Blind, Placebo-Controlled, Randomized Study Comparing 0.0003% Calcitriol with 0.1% Tacrolimus Ointments for the Treatment of Endemic Pityriasis Alba
title_full_unstemmed Double-Blind, Placebo-Controlled, Randomized Study Comparing 0.0003% Calcitriol with 0.1% Tacrolimus Ointments for the Treatment of Endemic Pityriasis Alba
title_short Double-Blind, Placebo-Controlled, Randomized Study Comparing 0.0003% Calcitriol with 0.1% Tacrolimus Ointments for the Treatment of Endemic Pityriasis Alba
title_sort double blind placebo controlled randomized study comparing 0 0003 calcitriol with 0 1 tacrolimus ointments for the treatment of endemic pityriasis alba
url http://dx.doi.org/10.1155/2012/303275
work_keys_str_mv AT berenicemorenocruz doubleblindplacebocontrolledrandomizedstudycomparing00003calcitriolwith01tacrolimusointmentsforthetreatmentofendemicpityriasisalba
AT berthatorresalvarez doubleblindplacebocontrolledrandomizedstudycomparing00003calcitriolwith01tacrolimusointmentsforthetreatmentofendemicpityriasisalba
AT dianahernandezblanco doubleblindplacebocontrolledrandomizedstudycomparing00003calcitriolwith01tacrolimusointmentsforthetreatmentofendemicpityriasisalba
AT juanpablocastanedocazares doubleblindplacebocontrolledrandomizedstudycomparing00003calcitriolwith01tacrolimusointmentsforthetreatmentofendemicpityriasisalba